Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

We’ve all seen the Norway fans rowing at baseball games, Americans screaming their hearts out to “Take Me Home, Country Roads,” and Scottish fans drinking all the beer in Boston. And in Miami. And at ...

Jillian Michaels described evolving her political views as like Neo in "The Matrix." "Honestly, it felt a bit like Neo in the Matrix at first because I really did think that, you know, when you're on ...

Matrix multiplication is a key operation in scientific computing and machine learning, with GPU libraries like NVIDIA Cutlass and cuBLAS providing optimized implementations of the three nested loop ...

D-Matrix says its chips can run inference workloads 10 times faster and using five times less energy than a standalone graphics processing unit from Nvidia. Like Cerebras, D-Matrix is trying to prove ...

One of the world’s leading artificial intelligence companies has implored the industry to pause development on AI, because the latest models could be reaching a tipping point where they become capable ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Best Penny Stocks with Huge Upside Potential. On May 14, Morgan Stanley raised the price target on Recursion Pharmaceuticals, Inc.

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Anthropic reveals that Claude now writes over 80% of its production code, with engineers shipping 8x more code per quarter than in 2024. The company’s new Anthropic Institute paper maps the path to ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...